Xiu M, Zhang P, Wang X, Fan Y, et al. Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant versus standard adjuvant chemotherapy in stage II to III triple-negative breast cancer: a prospective cohort study with propensity-matched analysis. Int J Cancer 2022 Apr 11. doi: 10.1002/ijc.34022.
PMID: 35403702